Report Feature
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the artificial intelligence in the global cancer market report, please download the report brochure.
By AI Tool [Value ($ Million) shipment analysis for 2014 – 2025]:
- Machine Learning
- Natural Language Processing
- Image Processing
- Speech Recognition
By Therapy [Value ($ Million) shipment analysis for 2014 – 2025]:
- Surgery & Chemotherapy
- Radiotherapy
- Immunotherapy
- Alteration of Tumor Microenvironment
- Phototherapy
- Theranostics
- Gene Therapy
- Hyperthermia Therapy
- Sonodynamic Therapy
By Algorithm Type [Value ($ Million) shipment analysis for 2014 – 2025]:
- Artificial Neural Networks
- Deep Learning
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
- Diagnosis
- Therapy
- Prognosis
- Health Management
- Research
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Germany
- France
-
Asia Pacific
- China
- India
- Japan
-
The Rest of the World
- Brazil
Some of the artificial intelligence in cancer companies profiled in this report include IBM, Digital Reasoning, Intel, Microsoft, Cancer Center.ai, Nvdia, Niramai Health Analytix, Johnson & Johnson, GE Healthcare, and Varian Medical Systems.
Lucintel forecasts that the surgery and chemotherapy will remain the largest therapy segment over the forecast period due to increasing prevalence of cancer and growing healthcare insurance & its reimbursement.
North America will remain the largest region over the forecast period due to increasing research and development activities related to cancer treatment and presence of developed healthcare infrastructure.
|
Features of the Artificial Intelligence in the Global Cancer Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global artificial intelligence in cancer market by AI tool (machine learning, natural language processing, image processing, and speech recognition), therapy (surgery & chemotherapy, radiotherapy, immunotherapy, alteration of tumor microenvironment, phototherapy, theranostics, gene therapy, hyperthermia therapy, and sonodynamic therapy), algorithm type (artificial neural networks and deep learning), application (diagnosis, therapy, prognosis, health management, and research), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global artificial intelligence in cancer market? Q.5 What are the business risks and threats to the global artificial intelligence in cancer market? Q.6 What are the emerging trends in this artificial intelligence in cancer market and the reasons behind them? Q.7 What are some changing demands of customers in this artificial intelligence in cancer market? Q.8 What are the new developments in this artificial intelligence in cancer market? Which companies are leading these developments? Q.9 Who are the major players in this artificial intelligence in cancer market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this artificial intelligence in cancer market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the artificial intelligence in the global cancer market? |
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | AI Tool (Machine Learning, Natural Language Processing, Image Processing, and Speech Recognition), Therapy (Surgery & Chemotherapy, Radiotherapy, Immunotherapy, Alteration of Tumor Microenvironment, Phototherapy, Theranostics, Gene Therapy, Hyperthermia Therapy, and Sonodynamic Therapy), Algorithm Type (Artificial Neural Networks and Deep Learning), and Application (Diagnosis, Therapy, Prognosis, Health Management, and Research) |
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
Methodology
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.